GGrantIndex
← Leaderboards

Ian Marriott

University Of North Carolina Charlotte

$5,101,438
Attributed
$7,655,722
Total exposure
10
Grants
7
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.3M · FY200625
$2M$1.5M$1M$500K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$7,655,722 · 10

By mechanism

R01$5,721,147 · 3
R21$815,826 · 2
R03$665,749 · 4
R15$453,000 · 1

Top collaborators

Most similar at University Of North Carolina Charlotte

Same institution · by research overlap

Others in their field

Top investigators on “Inflammation

Research focus

InflammationResponseProductionCellsInflammatoryMediatingSiteClinically RelevantPlayLeukocytesImmune ResponseInfectionCytokineStaphylococcus AureusBacterial InfectionsBacteriaInflammation MediatorsIn VivoPathogenPeripheralNeuraxisOsteoblastsAttenuatedOsteomyelitis

Grant awards (29)

Therapeutic potential of targeting glia as an inflammatory mediator source and bacterial reservoir$413,542
R21 · FY2025 · AI · contact PI
Augmenting host innate immune responses against Staphylococcal osteomyelitis with antimicrobial nucleic acid structures$402,284
R21 · FY2025 · AI
Substance P exacerbation of staphylococcal bone damage$382,454
R01 · FY2025 · AI · contact PI
Type I interferon responses of bone cells to Staphylococcus aureus: A pilot study$70,337
R03 · FY2025 · AI · contact PI
Substance P exacerbation of staphylococcal bone damage$382,474
R01 · FY2024 · AI · contact PI
Type I interferon responses of bone cells to Staphylococcus aureus: A pilot study$72,512
R03 · FY2024 · AI · contact PI
Substance P exacerbation of staphylococcal bone damage$382,504
R01 · FY2023 · AI · contact PI
Substance P exacerbation of staphylococcal bone damage$382,529
R01 · FY2022 · AI · contact PI
Substance P exacerbation of bone inflammation$453,000
R15 · FY2019 · AR · contact PI
Role of DAI in viral CNS infection: A pilot study$75,500
R03 · FY2018 · NS · contact PI
Role of DAI in viral CNS infection: A pilot study$75,500
R03 · FY2017 · NS · contact PI
Substance P exacerbation of CNS inflammation$432,291
R01 · FY2016 · NS · contact PI
Substance P exacerbation of CNS inflammation$438,417
R01 · FY2015 · NS · contact PI
Substance P exacerbation of CNS inflammation$456,817
R01 · FY2014 · NS · contact PI
Substance P exacerbation of CNS inflammation$630,904
R01 · FY2013 · NS · contact PI
Substance P exacerbation of CNS inflammation$670,258
R01 · FY2012 · NS · contact PI
Substance P exacerbation of CNS inflammation$251,683
R01 · FY2009 · NS · contact PI
Novel intracellular pattern recognition receptor expression by resident CNS cells$65,400
R03 · FY2009 · NS · contact PI
Substance P exacerbation of CNS inflammation$251,683
R01 · FY2008 · NS · contact PI
Novel intracellular pattern recognition receptor expression by resident CNS cells$72,000
R03 · FY2008 · NS · contact PI
Substance P exacerbation of CNS inflammation$251,683
R01 · FY2007 · NS · contact PI
Novel intracellular pattern recognition receptor expression by resident CNS cells$72,000
R03 · FY2007 · NS · contact PI
Substance P exacerbation of CNS inflammation$257,550
R01 · FY2006 · NS · contact PI
Osteoblast-derived inflammatory mediators in infection$183,300
R01 · FY2004 · AR
Osteoblast-derived inflammatory mediators in infection$183,300
R01 · FY2003 · AR
Bacterial infection induces cytokine production$32,500
R03 · FY2003 · AR
Osteoblast-derived inflammatory mediators in infection$183,300
R01 · FY2002 · AR
Bacterial infection induces cytokine production$65,000
R03 · FY2002 · AR
Bacterial infection induces cytokine production$65,000
R03 · FY2001 · AR